Skip to main navigation
Allogene Therapeutics
Contact Us
Careers
SHARE
Email Us
Print
Allogene Therapeutics
  • Pipeline
    • AlloCAR T Product Pipeline
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • Expanded Access
  • Science
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-demand Availability
    • SCIENTIFIC PUBLICATIONS
  • About Us
    • At A Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • News Center
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • IR Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Documents and Charters
      • Board of Directors
      • Management
      • Committee Composition
    • SEC Filings
    • Resources
      • Investor FAQs
      • Email Alerts
      • IR Inquiry

Committee Composition

Audit Committee Compensation Committee International and Business Development Oversight Committee Nominating and Corporate Governance Committee Research & Development Committee
Liz Barrett Audit Committee Compensation Committee
John DeYoung Compensation Committee International and Business Development Oversight Committee
Franz Humer, Ph.D. Compensation Committee International and Business Development Oversight Committee
Joshua Kazam International and Business Development Oversight Committee
Stephen Mayo, Ph.D. Audit Committee Research & Development Committee
Debbie Messemer Audit Committee Nominating and Corporate Governance Committee
Vicki Sato International and Business Development Oversight Committee Research & Development Committee
Todd Sisitsky Nominating and Corporate Governance Committee
Owen Witte, M.D. Nominating and Corporate Governance Committee Research & Development Committee
= Chairperson = Member = Lead Director = Financial Expert
Print Page
Email Alerts
RSS Feeds
Investor Contacts
Facebook
Twitter
LinkedIn
E-Mail
Tumblr
Reddit
WhatsApp
Telegram
Allogene Therapeutics
CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

View Map / Contact Us

  • Pipeline
  • AlloCAR T Product Pipeline
  • THE ALPHA3 TRIAL
  • THE RESOLUTION TRIAL
  • DATABRIEF
  • Expanded Access
  • Science
  • Next Revolution in Cell Therapy
  • Platform for Tomorrow
  • On-Demand Availability
  • Scientific Publications
  • About Us
  • At a Glance
  • Management Team
  • Board of Directors
  • Scientific Advisors
  • Partners
  • Corporate Responsibility
  • News Center
  • Press Releases
  • Events
  • Perspectives
  • Social Media
  • Community Guidelines
  • Investors
  • Press Releases
  • Events
  • Presentations
  • Stock Information
  • Stock Quote & Chart
  • Historical Price Look Up
  • Investment Calculator
  • Corporate Governance
  • Documents & Charters
  • Board of Directors
  • Management
  • Committee Composition
  • SEC Filings
  • Resources
  • Investor FAQs
  • Email Alerts
  • IR Inquiry
©2026 Allogene Therapeutics
TERMS OF USE
PRIVACY NOTICE